Metabolomics of beta-blockers
Carvedilol is a nonselective β-blocker with multiple properties, including antioxidant properties, α-adrenergic blocking effects and inhibitory effects on calcium channels. It has been used in the clinical treatment of hypertension and congestive heart failure. While it is known that each enantiomer...
Saved in:
主要作者: | Tan, Ian Yong Ming. |
---|---|
其他作者: | Chen Wei Ning, William |
格式: | Final Year Project |
語言: | English |
出版: |
2010
|
主題: | |
在線閱讀: | http://hdl.handle.net/10356/39680 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Membrane proteomics of cellular responses to β-blocker carvedilol
由: Wee, Kai Fa.
出版: (2010) -
Cellular response to synthetic drugs : a metabolomics approach
由: Chen, William Wei Ning.
出版: (2009) -
Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin
由: Bai, Jing
出版: (2011) -
Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol
由: Wang, Mingxuan
出版: (2012) -
Bioprocessing of human beta defensin-25
由: Tan, Alvin Leong Kiat.
出版: (2010)